While most investors remain focused on mega-cap technology and index performance, a different story has been developing beneath the surface. In a recent Market at closing Live, Senior Market Strategist John Rowland, CMT, highlighted a signal that often precedes sector leadership: broad participation, improving momentum, and confirmation of both economic data and price action.
That story is playing out right now in healthcare.
One of the most telling signs of a healthy trend isn’t the headlines; It is participation. When John looked at the healthcare sector, what immediately stood out was how many stocks were trading above their key moving averages.
Across the sector, a growing percentage of names remain above their 50-, 100-, and 200-day moving averages. That alignment indicates sustained demand, not just short-term speculation.
At the same time, the latest employment report added fuel to the thesis. Of the roughly 69,000 jobs added in the private sector, nearly two-thirds came from health care alone. That kind of concentration points to real economic momentum, not just market rotation.
This combination (technical strength coupled with labor market confirmation) is often where lasting trends begin.
Instead of guessing which healthcare names might work, John leaned on a framework taught by our Chart of the day Columnist Jim Van Meerten: If you want to do better, start by identifying stocks that already outperform the index.
Using Barchart’s market sector tools and custom views, healthcare stocks were ranked by weighted alpha, a metric designed to measure performance relative to the broader market. While the General Healthcare ETF (XLV) is performing roughly in line with the S&P 500 Index ($SPX), many individual names within the sector are already moving forward.
That dispersion is important. It tells us that leadership is emerging at the stock level, even if the sector ETF has yet to fully break out.
Bristol-Myers Squibb is a name John has followed (and owned) in the past, and he recently checked several boxes at once.
From a longer-term perspective, BMY had already been through a multi-year decline, resetting expectations and valuations. What changed was the structure. The stock began to form higher lows and then broke out of a well-defined range, indicating a shift from distribution to accumulation.
That breakout turned what started as a value idea into a momentum-driven trade, and the follow-through so far has been constructive. At current levels, John noted he would be more focused on managing gains and watching for consolidation, a reminder that momentum trading can evolve into longer-term investments when conditions remain favorable.
While BMY illustrates what healthcare momentum can look like once established, John also pointed to an opportunity in development, one that fits a very different profile.
American Healthcare REIT (AHR) operates in senior housing, skilled nursing, and physician offices, an area directly linked to one of the strongest secular trends in the U.S.: the aging population.
From a technical perspective, AHR is approaching a critical resistance zone near $48.50. Beating that level would complete the activation phase of a classic 3-Candle Drop reversal setup, a pattern John has traded throughout his career.
www.barchart.com
If the price can break and sustain above that level, the next resistance zone lies near $51, with a measured bullish target closer to $55. However, failure to remove the resistance would invalidate the setup, making it a rules-based, defined risk trade rather than a prediction.
Importantly, this technical setup is reinforced by fundamentals. AHR has completed more than $950 million in acquisitions so far this year, focusing squarely on operating senior healthcare assets that management expects to drive growth through 2026 and beyond.
John has disclosed that he owns the stock, reinforcing that this is not a hypothetical chart pattern, but rather an actively monitored opportunity.
Healthcare doesn’t move like high beta technology. It rarely makes headlines at the top or bottom. Instead, it tends to be built quietly, supported by demographics, job growth and steady capital deployment.
At this moment, the sector is showing:
Improving subsurface amplitude
Individual Stocks Outperforming the Index
Technical structures move from the base to the trend
Real-world economic demand supports price action
That combination is exactly what traders and investors should pay attention to.
You can follow this same process using Barchart tools:
See S&P Market Performance and Sectors for Health Care Stock Lists
Screen using custom views sorted by weighted alpha
Use interactive charts to monitor moving averages and resistance levels.
Check out our education on candlestick patterns including 3 candlestick dip
Healthcare doesn’t need advertising to work, it just needs confirmation. And right now, graphics are starting to provide it.
As of the date of publication, Barchart Insights had no (directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com
